Compare FCNCA & LH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | FCNCA | LH |
|---|---|---|
| Founded | 1898 | 1971 |
| Country | United States | United States |
| Employees | 18141 | 70000 |
| Industry | Major Banks | Medical Specialities |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 24.4B | 21.0B |
| IPO Year | N/A | 2005 |
| Metric | FCNCA | LH |
|---|---|---|
| Price | $2,071.34 | $278.83 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 11 | 9 |
| Target Price | ★ $2,199.64 | $311.33 |
| AVG Volume (30 Days) | 81.8K | ★ 577.6K |
| Earning Date | 04-23-2026 | 04-30-2026 |
| Dividend Yield | 0.43% | ★ 1.12% |
| EPS Growth | N/A | ★ 18.33 |
| EPS | N/A | ★ 3.35 |
| Revenue | N/A | ★ $13,951,700,000.00 |
| Revenue This Year | $3.43 | $8.26 |
| Revenue Next Year | N/A | $4.81 |
| P/E Ratio | ★ $12.17 | $83.69 |
| Revenue Growth | N/A | ★ 7.25 |
| 52 Week Low | $1,625.08 | $244.52 |
| 52 Week High | $2,232.21 | $293.72 |
| Indicator | FCNCA | LH |
|---|---|---|
| Relative Strength Index (RSI) | 48.72 | 56.30 |
| Support Level | $2,024.44 | $260.84 |
| Resistance Level | $2,135.18 | $291.94 |
| Average True Range (ATR) | 57.16 | 7.15 |
| MACD | -4.13 | -0.29 |
| Stochastic Oscillator | 32.82 | 58.38 |
First Citizens is a US regional bank with total assets of around $236 billion as of March 31, 2026. Headquartered in Raleigh, North Carolina, First Citizens' largest markets are North Carolina, South Carolina, and California. The bank has a track record of acquiring troubled banks from the FDIC, such as Silicon Valley Bridge Bank in 2023, which doubled its asset base. First Citizens offers products and services across retail, commercial, wealth management, and railcar leasing. First Citizens derived over 95% of its earnings from banking and less than 5% from railcar leasing in 2025.
Labcorp is one of the nation's two largest independent clinical laboratories, with roughly 20% of the independent lab market. The company operates approximately 2,000 patient-service centers, offering a broad range of 5,000 clinical lab tests, ranging from uncomplicated routine blood and urine screens to complex oncology and genomic testing.